Literature DB >> 15140785

Successful treatment of genital ulcers with infliximab in Behcet's disease.

G Haugeberg, M Velken, V Johnsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15140785      PMCID： PMC1755019          DOI： 10.1136/ard.2003.010975

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  [Clinical aspects and treatment of recurrent aphthous ulcers].

Authors:  A Altenburg; C K Micheli; C Maldini; A Mahr; M Puttkammer; C C Zouboulis
Journal:  Hautarzt       Date:  2012-09       Impact factor: 0.751

2.  Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.

Authors:  Ji Hyeon Ju; Seung-Ki Kwok; Soo-Hong Seo; Chong-Hyeon Yoon; Ho-Youn Kim; Sung-Hwan Park
Journal:  Clin Rheumatol       Date:  2006-10-13       Impact factor: 2.980

3.  Successful treatment with adalimumab in a patient with coexisting Behçet's disease and ankylosing spondylitis.

Authors:  Necmettin Yildiz; Hakan Alkan; Fusun Ardic; Oya Topuz
Journal:  Rheumatol Int       Date:  2009-08-25       Impact factor: 2.631

4.  Safety and efficacy of infliximab therapy in active behcet's uveitis: an open-label trial.

Authors:  H Al-Rayes; R Al-Swailem; M Al-Balawi; N Al-Dohayan; S Al-Zaidi; M Tariq
Journal:  Rheumatol Int       Date:  2008-05-22       Impact factor: 2.631

Review 5.  Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.

Authors:  Cinzia Rotondo; Giuseppe Lopalco; Florenzo Iannone; Antonio Vitale; Rosaria Talarico; Mauro Galeazzi; Giovanni Lapadula; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2015-06-22       Impact factor: 4.711

6.  Safety and efficacy of infliximab in the treatment of refractory uveoretinitis in Behçet's disease: a large-scale, long-term postmarketing surveillance in Japan.

Authors:  Shigeaki Ohno; Itsuro Umebayashi; Miyuki Matsukawa; Takashi Goto; Toshiro Yano
Journal:  Arthritis Res Ther       Date:  2019-01-05       Impact factor: 5.156

7.  Remission of severe aphthous stomatitis of celiac disease with etanercept.

Authors:  Adey Hasan; Hiren Patel; Hana Saleh; George Youngberg; John Litchfield; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2013-12-24

Review 8.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.